5,7-Dihydroxytryptamine hydrobromide

Synonyms: 5,7-DHP hydrobromide
5,7-Dihydroxytryptamine (5,7-DHT) hydrobromide 是一种自发荧光 (Ex ≈ 365 nm)、选择性神经毒素,是 MAO-A 和 5-HT 的转运底物,可特异性靶向并损毁中枢及外周的 5-HT 能神经元,同时影响 5-HT 相关通路及神经递质平衡,因此可用于构建 5-HT 能神经元损伤模型,以研究神经发育、神经退行性疾病以及血小板功能和视网膜神经元相关机制。
产品编号: MS-M55585 CAS No.: 1841081-30-8 分子式: C10H13BrN2O2 分子量: 273.13
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

5,7-Dihydroxytryptamine (5,7-DHT) hydrobromide 是一种自发荧光 (Ex ≈ 365 nm)、选择性神经毒素,是 MAO-A 和 5-HT 的转运底物,可特异性靶向并损毁中枢及外周的 5-HT 能神经元,同时影响 5-HT 相关通路及神经递质平衡,因此可用于构建 5-HT 能神经元损伤模型,以研究神经发育、神经退行性疾病以及血小板功能和视网膜神经元相关机制。

生物实验数据

生物活性 5,7-Dihydroxytryptamine (5,7-DHT) hydrobromide is an autofluorescent (Ex ≈ 365 nm), selective neurotoxin and a transport substrate of MAO-A and 5-HT that specifically targets and destroys central and peripheral serotonergic neurons while affecting 5-HT-related pathways and neurotransmitter balance, and can therefore be used to establish serotonergic neuron injury models for studying neurodevelopment, neurodegenerative diseases, and mechanisms related to platelet function and retinal neurons.
体外研究
(In Vitro)

5,7-dihydroxytryptamine hydrobromide (25 μM;37°C;60 min) 可特异性标记取自 14 日龄 Wistar 大鼠胎鼠的 10 日龄原代中脑培养物中的 5-羟色胺能细胞 (但不标记多巴胺能细胞)。

体内研究
(In Vivo)

5,7-Dihydroxytryptamine (12.5-50.0 μg;脑室内给药;单剂量) hydrobromide 可耗尽小鼠海马体中的去甲肾上腺素和 5-HT,其中去甲肾上腺素的耗竭可被非选择性 MAO 抑制作用阻断,但无法被选择性 MAO-B 抑制作用阻断。
5,7-Dihydroxytryptamine (10 μg 碱基;侧脑室注射;单次给药;惊厥诱导前 10 天) hydrobromide 可耗竭大鼠脊髓中的 5-HT 水平,但不影响电诱导的大鼠脊髓惊厥。

Animal Model: Wistar rats (adult male, 175-200 g at surgery)
Dosage: 8 μg
Administration: bilateral stereotaxic infusion into nucleus accumbens; over 2 min, injector left in place for 1 additional min post-infusion
Result: Increased mean amplitude of the acoustic startle reflex significantly across all stimulus intensities in the absence of background noise compared to the Sham-lesion group.
Showed no significant differences in startle amplitude between the DHT-lesion, Sham-lesion, and intact groups at any stimulus intensity in the presence of background noise.
Confirmed nearly complete loss of serotonergic neurons in the nucleus accumbens via immunohistochemistry.
Animal Model: C57BL/6 (male, 2 and 10 months old, 20-30 g)
Dosage: 12.5 μg; 25 μg; 50 μg
Administration: i.c.v.; single dose
Result: Had a damaging effect on the noradrenergic system, and this effect was independent of the age of the mice.
Exerted stronger toxic effects on serotonergic neurons in young individuals.
Animal Model: M/511-Wistar (male, 240-280 g)
Dosage: 4 µg (calculated as the base) per injection site
Administration: stereotactic injection; 1 µl/min rate; needle left in situ for 1 min post-injection
Result: Reduced ³H-5-HT uptake but did not change ³H-NA uptake in the cortex (medial bundle lesion group).
Reduced ³H-NA uptake to 75% of control (non-significant) in the cortex (medial plus lateral bundle lesion group).
Induced mouse killing behavior in 4 of 8 rats (medial bundle lesion group) and 6 of 7 rats (medial plus lateral bundle lesion group).
Required significantly more trials to reach habituation criterion for touch (both lesion groups).
Required significantly more trials for acoustic stimulation habituation (only medial plus lateral lesion group).
Showed a significantly higher number of boxing positions in the shock elicited fighting test (both lesion groups).
Showed no significant changes in home cage activity (both lesion groups).

化学信息

分子量 273.13
分子式 C10H13BrN2O2
CAS No. 1841081-30-8
别名 5,7-DHP hydrobromide

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础